D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 103.2 SEK 0.19% Market Closed
Market Cap: kr1.7B

Wall Street
Price Targets

DVYSR Price Targets Summary
Devyser Diagnostics AB

Wall Street analysts forecast DVYSR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DVYSR is 169.32 SEK with a low forecast of 163.62 SEK and a high forecast of 178.5 SEK.

Lowest
Price Target
163.62 SEK
59% Upside
Average
Price Target
169.32 SEK
64% Upside
Highest
Price Target
178.5 SEK
73% Upside
Devyser Diagnostics AB Competitors:
Price Targets
FBIZ
First Business Financial Services Inc
7% Upside
GOSS
Gossamer Bio Inc
250% Upside
EBMT
Eagle Bancorp Montana Inc
-12% Downside
ZNTL
Zentalis Pharmaceuticals Inc
67% Upside
PTEN
Patterson-UTI Energy Inc
-1% Downside

Revenue
Forecast

28% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
28% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 5 years the compound annual growth rate for Devyser Diagnostics AB's revenue is 28%. The projected CAGR for the next 4 years is 36%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
27%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
27%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DVYSR's stock price target?
Price Target
169.32 SEK

According to Wall Street analysts, the average 1-year price target for DVYSR is 169.32 SEK with a low forecast of 163.62 SEK and a high forecast of 178.5 SEK.

What is Devyser Diagnostics AB's Revenue forecast?
Projected CAGR
36%

For the last 5 years the compound annual growth rate for Devyser Diagnostics AB's revenue is 28%. The projected CAGR for the next 4 years is 36%.

Back to Top